DeepHealth vs Iterative Health

DeepHealth, a RadNet subsidiary, sells to radiology departments that read breast and prostate studies. Its home page lists SmartMammo, prostate, lung, brain and thyroid tools, and openFDA holds ten records under DeepHealth, Inc., among them Saige-Dx and Saige-Density. RadNet closed the iCAD purchase in July 2025 and announced Gleamer in March 2026. The Saige-Dx reader study in Radiology: AI reports a reader AUC of 0.93 across 18 readers and 240 cases, written by DeepHealth employees on a retrospective, enriched set.

SKOUT from Iterative Health detects polyps on the live colonoscopy video feed. A gastroenterology group adding detection to its colonoscopy towers is the buyer, and the page offers a demo request only. The 2022 Gastroenterology randomized trial was sponsor-run: 22 endoscopists at five centers, 677 standard and 682 CADe colonoscopies, and 0.83 adenomas per colonoscopy without SKOUT against 1.05 with it (P=.002). The detection rate gain from 43.9% to 47.8% missed significance (P=.065).

A breast imager works with DeepHealth, an endoscopist with SKOUT. Iterative Health's home page now leads with clinical research, and the vendor's home page headline says it closed a $77 million Series C.